anonymous
Guest
anonymous
Guest
Thing was filed in 2014, three years after we launched (WTF?) and covers a method of use to treat a patient with lurasidone without gaining weight. We are trying to block generics with a patent on a method of use we are not even indicated for. Also doesn’t cover the 160mg dose. Generics will carve around this thing without even trying. Whoever thinks this is holding up to 2024 is a fool.